Advertisement

Topics

Takeda pays $100mm up front for rights to Tesaro's niraparib

15:40 EDT 28 Jul 2017 | Elsevier Business Intelligence

Tesaro Inc. granted Takeda Pharmaceutical Co. Ltd. exclusive rights in certain Asian countries to niraparib, a poly ADP-ribos...

Original Article: Takeda pays $100mm up front for rights to Tesaro's niraparib

NEXT ARTICLE

More From BioPortfolio on "Takeda pays $100mm up front for rights to Tesaro's niraparib"

Quick Search
Advertisement
 

Relevant Topics

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...